Publications
5674 Results
- Journal / Conference
- Biometrics 55:204-213
- Year
- 1999
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8229/30
Adaptive regression splines in the cox model
- Journal / Conference
- Controlled Clinical Trials 20:343-352
- Year
- 1999
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8835
False positive rates of randomized phase II designs
- Journal / Conference
- Nature Genetics 23:166-175
- Year
- 1999
- Research Committee(s)
- Leukemia
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
- Journal / Conference
- Journal of Clinical Oncology 17(11):3389-3395
- Year
- 1999
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9340 (RTOG-9404)
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: a retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy
- Journal / Conference
- Journal of the National Cancer Institute 91(4):381-382
- Year
- 1999
- Research Committee(s)
- Genitourinary
Response to Letter to the Editor: Re: Quality of life in advanced prostate cancer: results of a randomized therapeutic trial
- Journal / Conference
- Cancer Therapeutics 1(4):229-236
- Year
- 1998
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8300
A randomized trial of chemotherapy and Radiotherapy for stage III non-small cell lung cancer.
- Journal / Conference
- Journal of Clinical Oncology 16(4):1310-1317
- Year
- 1998
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099.
- Journal / Conference
- Journal of Clinical Oncology 16(1):48-55
- Year
- 1998
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8942
Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: Value of augmented preparative regimens-A Southwest Oncology Group trial.
- Journal / Conference
- Cancer 82(7):1288-1295
- Year
- 1998
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8616 (INT-0072)
A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma and rhabdomyosarcoma.
- Journal / Conference
- Journal of Clinical Oncology 16(3):994-999
- Year
- 1998
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8692 (INT-0075)